Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Seed SM et al. – Treatment options have primarily focused on alleviating the pain often associated with this condition. Acetaminophen and nonsteroidal antiinflammatory drugs (NSAIDs) are often employed for relief of mild–to–moderate pain associated with OA. NSAIDs are typically more effective than acetaminophen; however, because of adverse effects associated with long–term use of NSAIDs, acetaminophen is considered first–line therapy. Safety concerns over traditional pharmacotherapeutic agents used in the management of OA, such as NSAIDs and opioids, have led healthcare professionals to seek other options. Trials of diseasemodulating agents that focus on preventing further damage to the joints have the potential to change how this disease state is managed. This article reviews nonpharmacologic and pharmacologic approaches to management of OA of the knee and hip.
Today in Arthritis/Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: A randomized controlled trial
Journal of Rehabilitation Medicine, 11/20/09
Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis
Arthritis Care and Research , 11/04/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150mg and risedronate 150mg
Current Medical Research and Opinion, 10/22/09
Article Search
Sponsor


See Latest Articles


